Biovigilance for the quality and safety of medical products of human origin

M Herson, G Weaver - Maternal & Child Nutrition, 2024 - Wiley Online Library

This paper explores the legislative and operational commonalities and differences in
Medical Products of Human Origin (MPHO) programs, including blood, hematopoietic cells …

被引用次数：3 相关文章所有 4 个版本

Adverse events reporting systems in cells, organs, and tissues donation and transplantation: scoping review

SM Schuantes-Paim, LF Wachholz, NDS Knihs… - Transplantation …, 2023 - Elsevier

Background This study aimed to map adverse events reporting systems in cells, organs, and
tissues donation and transplantation, including the terms applicable in each system and …

被引用次数：4 相关文章所有 3 个版本

[HTML] sciencedirect.com

[HTML][HTML] Biovigilance systems: Cells, tissues, and organs donation and transplantation

B de Aguiar Roza, SM Schuantes-Paim… - Transplantation …, 2024 - Elsevier

Abstract Objective: to describe Biovigilance Systems and their associated management tools
among member countries of the World Health Organization. Method: overview conducted …

《移植器官质量与安全指南》解读--生物安全性预警.

沈国杰，屠振华 - Organ Transplantation/Qi Guan Yi Zhi, 2020 - search.ebscohost.com

随着器官捐献和移植事业的蓬勃发展, 完善管理体系, 确保移植器官的质量和安全也越来越重要.
欧盟的《移植器官质量与安全指南(第6 版)》在生物安全性预警方面提出了严重不良反应和严重 …

Hematopoietic Stem Cell Donor Registries: Search Strategies and HLA Methodologies

C Stavropoulos, V Gkioka… - Hematopoietic Stem Cell …, 2021 - taylorfrancis.com

The complexity and expense in identifying an ideal allogeneic hematopoietic stem cell
donor is due to the high polymorphism of the HLA genes. Every HLA antigen mismatch …

[PDF] researchgate.net

[PDF][PDF] Transplantation Reports

B de Aguiar Roza, SM Schuantes-Paim, PC Oliveira… - researchgate.net

ABSTRACT Objective: to describe Biovigilance Systems and their associated management
tools among member countries of the World Health Organization. Method: overview …